Patents Assigned to Resolvyx Pharmaceuticals, Inc.
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
    Publication number: 20130316989
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: RESOLVYX PHARMACEUTICALS, INC.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION
    Publication number: 20120122816
    Abstract: The invention relates to reducing, preventing or reversing organ damage, reducing and/or preventing stem cell damage and/or death, enhancing organ preservation and/or survival, or enhancing stem cell preservation and/or survival comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, an oxylipin compound, or a combination of aspirin and an omega-3 fatty acid.
    Type: Application
    Filed: February 5, 2010
    Publication date: May 17, 2012
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
    Publication number: 20110190242
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: September 23, 2009
    Publication date: August 4, 2011
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Compositions and methods for modulating immune function
    Publication number: 20090137527
    Abstract: The invention relates to methods of modulating immune function, suppressing immune response, treating autoimmune diseases or autoimmune disorders, and treating diseases, sequelae or pathological conditions mediated by an activation of the immune system comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: September 12, 2008
    Publication date: May 28, 2009
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventors: Per Gjorstrup, Shixin Qin, Lijun Wu
  • Compositions and methods for the treatment of ophthalmic conditions
    Publication number: 20090118243
    Abstract: The invention relates to methods of treating ophthalmic conditions comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: October 10, 2008
    Publication date: May 7, 2009
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Publication number: 20080207753
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Applicants: Resolvyx Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Compounds and methods for inhibition of bone loss
    Publication number: 20080161274
    Abstract: The invention relates to methods of treating or preventing bone loss, as in osteoporosis, metastatic bone disease, or periodontitis, comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: October 26, 2007
    Publication date: July 3, 2008
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventors: Per Gjorstrup, Matthew James Nichols
  • Compositions and methods for the treatment of inflammatory disease
    Publication number: 20080161275
    Abstract: The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
    Type: Application
    Filed: December 5, 2007
    Publication date: July 3, 2008
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Patent number: 7378444
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: May 27, 2008
    Assignees: Brigham and Women's Hospital, Inc., Resolvyx Pharmaceuticals, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Compositions and methods for the treatment of cardiovascular disease
    Publication number: 20070254897
    Abstract: The invention relates to methods of treating cardiovascular disease comprising administering a resolvin, lipoxin, or oxylipin compound.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 1, 2007
    Applicant: Resolvyx Pharmaceuticals, Inc.
    Inventor: Per Gjorstrup